Advertisement

Index by author

December 01, 1999; Volume 27,Issue 12

A

  1. Abe, Seiji

    1. Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
      Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
      Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;

B

  1. Baldassano, Robert N.

    1. Up-Regulation of Glutathione S-Transferase Activity in Enterocytes of Young Children
      John P. Gibbs, Chris A. Liacouras, Robert N. Baldassano and John T. Slattery
      Drug Metabolism and Disposition December 1999, 27 (12) 1466-1469;

  2. Bandiera, Stelvio M.

    1. Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen
      Masahiko Kawai, Stelvio M. Bandiera, Thomas K. H. Chang, Frederique M. Poulet, Paul M. Vancutsem and Gail D. Bellward
      Drug Metabolism and Disposition December 1999, 27 (12) 1392-1398;

  3. Bellward, Gail D.

    1. Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen
      Masahiko Kawai, Stelvio M. Bandiera, Thomas K. H. Chang, Frederique M. Poulet, Paul M. Vancutsem and Gail D. Bellward
      Drug Metabolism and Disposition December 1999, 27 (12) 1392-1398;

  4. Benet, Leslie Z.

    1. Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
      Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
      Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;

  5. Bergeron, Raymond J.

    1. Pharmacokinetics of Orally Administered Desferrithiocin Analogs in Cebus apella Primates
      Raymond J. Bergeron, William R. Weimar and Jan Wiegand
      Drug Metabolism and Disposition December 1999, 27 (12) 1496-1498;

  6. Beydon, Dominique

    1. Toxicokinetics of 1,2-Diethylbenzene in Male Sprague-Dawley Rats—Part 1: Excretion and Metabolism of [14C]1,2-Diethylbenzene
      Jean-Paul Payan, Dominique Beydon, Benoît Cossec, André Ensminger, Jean-Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition December 1999, 27 (12) 1470-1478;

  7. Biefang, Katja

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

  8. Bornheim, Lester M.

    1. Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
      Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
      Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;

  9. Böttger, Thomas

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

  10. Bulitta, Clemens

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

C

  1. Casley, William L.

    1. Detection of Quantitative Trait Loci Affecting Caffeine Metabolism by Interval Mapping in a Genome-Wide Scan of C3H/HeJ × APN F2 Mice
      William L. Casley, J. Allan Menzies, Larry W. Whitehouse and Thomas W. Moon
      Drug Metabolism and Disposition December 1999, 27 (12) 1375-1380;

  2. Chang, Thomas K. H.

    1. Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen
      Masahiko Kawai, Stelvio M. Bandiera, Thomas K. H. Chang, Frederique M. Poulet, Paul M. Vancutsem and Gail D. Bellward
      Drug Metabolism and Disposition December 1999, 27 (12) 1392-1398;

  3. Chiba, Kan

    1. Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
      Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
      Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;
    2. Response to Letter to the Editor
      Kaoru Kobayashi, Miki Nakajima, Kanako Oshima, Noriaki Shimada, Tsuyoshi Yokoi and Kan Chiba
      Drug Metabolism and Disposition December 1999, 27 (12) 1521-1522;

  4. Correia, Maria Almira

    1. Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
      Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
      Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;

  5. Cossec, Benoît

    1. Toxicokinetics of 1,2-Diethylbenzene in Male Sprague-Dawley Rats—Part 1: Excretion and Metabolism of [14C]1,2-Diethylbenzene
      Jean-Paul Payan, Dominique Beydon, Benoît Cossec, André Ensminger, Jean-Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition December 1999, 27 (12) 1470-1478;

  6. Crooks, Peter A.

    1. Residence Times and Half-Lives of Nicotine Metabolites in Rat Brain after Acute Peripheral Administration of [2′-14C]Nicotine
      Omar Ghosheh, Linda P. Dwoskin, Wen-Kui Li and Peter A. Crooks
      Drug Metabolism and Disposition December 1999, 27 (12) 1448-1455;

  7. Currie, Catherine

    1. Enhancement of Platinum-Drug Cytotoxicity in a Human Head and Neck Squamous Cell Carcinoma Line and its Platinum-Resistant Variant by Liposomal Amphotericin B and Phospholipase A2-II
      Peter J. Ferguson, Catherine Currie and Mark D. Vincent
      Drug Metabolism and Disposition December 1999, 27 (12) 1399-1405;

D

  1. Davidson, Walter C.

    1. Biotransformation of Nevirapine, a Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor, in Mice, Rats, Rabbits, Dogs, Monkeys, and Chimpanzees
      Paul S. Riska, David P. Joseph, Roger M. Dinallo, Walter C. Davidson, James J. Keirns and Susan E. Hattox
      Drug Metabolism and Disposition December 1999, 27 (12) 1434-1447;

  2. De Costa, Kristi S.

    1. Absorption, Metabolism, and Disposition of 1,3-Diphenyl-1-Triazene in Rats and Mice after Oral, i.v., and Dermal Administration
      James M. Mathews and Kristi S. De Costa
      Drug Metabolism and Disposition December 1999, 27 (12) 1499-1504;

  3. Dinallo, Roger M.

    1. Biotransformation of Nevirapine, a Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor, in Mice, Rats, Rabbits, Dogs, Monkeys, and Chimpanzees
      Paul S. Riska, David P. Joseph, Roger M. Dinallo, Walter C. Davidson, James J. Keirns and Susan E. Hattox
      Drug Metabolism and Disposition December 1999, 27 (12) 1434-1447;

  4. Dong, Jennifer Q.

    1. Effect of Selective Phase II Enzyme Inducers on Glucuronidation of Benoxaprofen in Rats
      Jennifer Q. Dong, Amy S. Etheridge and Philip C. Smith
      Drug Metabolism and Disposition December 1999, 27 (12) 1423-1428;

  5. Dwoskin, Linda P.

    1. Residence Times and Half-Lives of Nicotine Metabolites in Rat Brain after Acute Peripheral Administration of [2′-14C]Nicotine
      Omar Ghosheh, Linda P. Dwoskin, Wen-Kui Li and Peter A. Crooks
      Drug Metabolism and Disposition December 1999, 27 (12) 1448-1455;

E

  1. Ensminger, André

    1. Toxicokinetics of 1,2-Diethylbenzene in Male Sprague-Dawley Rats—Part 1: Excretion and Metabolism of [14C]1,2-Diethylbenzene
      Jean-Paul Payan, Dominique Beydon, Benoît Cossec, André Ensminger, Jean-Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition December 1999, 27 (12) 1470-1478;

  2. Erickson, David A.

    1. Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450
      David A. Erickson, Gary Mather, William F. Trager, Rene H. Levy and James J. Keirns
      Drug Metabolism and Disposition December 1999, 27 (12) 1488-1495;

  3. Etheridge, Amy S.

    1. Effect of Selective Phase II Enzyme Inducers on Glucuronidation of Benoxaprofen in Rats
      Jennifer Q. Dong, Amy S. Etheridge and Philip C. Smith
      Drug Metabolism and Disposition December 1999, 27 (12) 1423-1428;

F

  1. Fabry, Jean-Paul

    1. Toxicokinetics of 1,2-Diethylbenzene in Male Sprague-Dawley Rats—Part 1: Excretion and Metabolism of [14C]1,2-Diethylbenzene
      Jean-Paul Payan, Dominique Beydon, Benoît Cossec, André Ensminger, Jean-Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition December 1999, 27 (12) 1470-1478;

  2. Ferguson, Peter J.

    1. Enhancement of Platinum-Drug Cytotoxicity in a Human Head and Neck Squamous Cell Carcinoma Line and its Platinum-Resistant Variant by Liposomal Amphotericin B and Phospholipase A2-II
      Peter J. Ferguson, Catherine Currie and Mark D. Vincent
      Drug Metabolism and Disposition December 1999, 27 (12) 1399-1405;

  3. Ferrari, Elisabeth

    1. Toxicokinetics of 1,2-Diethylbenzene in Male Sprague-Dawley Rats—Part 1: Excretion and Metabolism of [14C]1,2-Diethylbenzene
      Jean-Paul Payan, Dominique Beydon, Benoît Cossec, André Ensminger, Jean-Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition December 1999, 27 (12) 1470-1478;

  4. Fischer, Thomas

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

G

  1. Ghosheh, Omar

    1. Residence Times and Half-Lives of Nicotine Metabolites in Rat Brain after Acute Peripheral Administration of [2′-14C]Nicotine
      Omar Ghosheh, Linda P. Dwoskin, Wen-Kui Li and Peter A. Crooks
      Drug Metabolism and Disposition December 1999, 27 (12) 1448-1455;

  2. Gibbs, John P.

    1. Up-Regulation of Glutathione S-Transferase Activity in Enterocytes of Young Children
      John P. Gibbs, Chris A. Liacouras, Robert N. Baldassano and John T. Slattery
      Drug Metabolism and Disposition December 1999, 27 (12) 1466-1469;

  3. Greenblatt, David J.

    1. CYP2C9 Is a Principal Low-Affinity Phenacetin O-Deethylase: Fluvoxamine Is Not a Specific CYP1A2 Inhibitor.
      Karthik Venkatakrishnan, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition December 1999, 27 (12) 1519-1520;

H

  1. Halladay, Jason S.

    1. Metabolism and Disposition of [14C]1-Nitronaphthalene in Male Sprague-Dawley Rats
      Jason S. Halladay, John-Michael Sauer and I. Glenn Sipes
      Drug Metabolism and Disposition December 1999, 27 (12) 1456-1465;

  2. Hansen, Linda K.

    1. Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs
      Vinayak P. Hosagrahara, Linda K. Hansen and Rory P. Remmel
      Drug Metabolism and Disposition December 1999, 27 (12) 1512-1518;

  3. Hanstein, Walter G.

    1. Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
      Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
      Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;

  4. Hattox, Susan E.

    1. Biotransformation of Nevirapine, a Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor, in Mice, Rats, Rabbits, Dogs, Monkeys, and Chimpanzees
      Paul S. Riska, David P. Joseph, Roger M. Dinallo, Walter C. Davidson, James J. Keirns and Susan E. Hattox
      Drug Metabolism and Disposition December 1999, 27 (12) 1434-1447;

  5. Hengstler, Jan

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

  6. Hosagrahara, Vinayak P.

    1. Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs
      Vinayak P. Hosagrahara, Linda K. Hansen and Rory P. Remmel
      Drug Metabolism and Disposition December 1999, 27 (12) 1512-1518;

J

  1. Jäger, Walter

    1. Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
      Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
      Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;

  2. Joseph, David P.

    1. Biotransformation of Nevirapine, a Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor, in Mice, Rats, Rabbits, Dogs, Monkeys, and Chimpanzees
      Paul S. Riska, David P. Joseph, Roger M. Dinallo, Walter C. Davidson, James J. Keirns and Susan E. Hattox
      Drug Metabolism and Disposition December 1999, 27 (12) 1434-1447;

K

  1. Kawai, Masahiko

    1. Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen
      Masahiko Kawai, Stelvio M. Bandiera, Thomas K. H. Chang, Frederique M. Poulet, Paul M. Vancutsem and Gail D. Bellward
      Drug Metabolism and Disposition December 1999, 27 (12) 1392-1398;

  2. Keirns, James J.

    1. Biotransformation of Nevirapine, a Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor, in Mice, Rats, Rabbits, Dogs, Monkeys, and Chimpanzees
      Paul S. Riska, David P. Joseph, Roger M. Dinallo, Walter C. Davidson, James J. Keirns and Susan E. Hattox
      Drug Metabolism and Disposition December 1999, 27 (12) 1434-1447;
    2. Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450
      David A. Erickson, Gary Mather, William F. Trager, Rene H. Levy and James J. Keirns
      Drug Metabolism and Disposition December 1999, 27 (12) 1488-1495;

  3. Kempf, Peter

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

  4. Kiulies, Sandra

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

  5. Kobayashi, Kaoru

    1. Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
      Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
      Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;
    2. Response to Letter to the Editor
      Kaoru Kobayashi, Miki Nakajima, Kanako Oshima, Noriaki Shimada, Tsuyoshi Yokoi and Kan Chiba
      Drug Metabolism and Disposition December 1999, 27 (12) 1521-1522;

L

  1. Levy, Rene H.

    1. Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450
      David A. Erickson, Gary Mather, William F. Trager, Rene H. Levy and James J. Keirns
      Drug Metabolism and Disposition December 1999, 27 (12) 1488-1495;

  2. Li, Wen-Kui

    1. Residence Times and Half-Lives of Nicotine Metabolites in Rat Brain after Acute Peripheral Administration of [2′-14C]Nicotine
      Omar Ghosheh, Linda P. Dwoskin, Wen-Kui Li and Peter A. Crooks
      Drug Metabolism and Disposition December 1999, 27 (12) 1448-1455;

  3. Liacouras, Chris A.

    1. Up-Regulation of Glutathione S-Transferase Activity in Enterocytes of Young Children
      John P. Gibbs, Chris A. Liacouras, Robert N. Baldassano and John T. Slattery
      Drug Metabolism and Disposition December 1999, 27 (12) 1466-1469;

M

  1. Mahnke, Axel

    1. Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
      Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
      Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;

  2. Mather, Gary

    1. Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450
      David A. Erickson, Gary Mather, William F. Trager, Rene H. Levy and James J. Keirns
      Drug Metabolism and Disposition December 1999, 27 (12) 1488-1495;

  3. Mathews, James M.

    1. Absorption, Metabolism, and Disposition of 1,3-Diphenyl-1-Triazene in Rats and Mice after Oral, i.v., and Dermal Administration
      James M. Mathews and Kristi S. De Costa
      Drug Metabolism and Disposition December 1999, 27 (12) 1499-1504;

  4. Matsui, Kenji

    1. Absorption, Distribution, Metabolism, and Excretion of Donepezil (Aricept) after a Single Oral Administration to Rat
      Kenji Matsui, Mannen Mishima, Yasushi Nagai, Teruaki Yuzuriha and Tsutomu Yoshimura
      Drug Metabolism and Disposition December 1999, 27 (12) 1406-1414;

  5. Menzies, J. Allan

    1. Detection of Quantitative Trait Loci Affecting Caffeine Metabolism by Interval Mapping in a Genome-Wide Scan of C3H/HeJ × APN F2 Mice
      William L. Casley, J. Allan Menzies, Larry W. Whitehouse and Thomas W. Moon
      Drug Metabolism and Disposition December 1999, 27 (12) 1375-1380;

  6. Mishima, Mannen

    1. Absorption, Distribution, Metabolism, and Excretion of Donepezil (Aricept) after a Single Oral Administration to Rat
      Kenji Matsui, Mannen Mishima, Yasushi Nagai, Teruaki Yuzuriha and Tsutomu Yoshimura
      Drug Metabolism and Disposition December 1999, 27 (12) 1406-1414;

  7. Moon, Thomas W.

    1. Detection of Quantitative Trait Loci Affecting Caffeine Metabolism by Interval Mapping in a Genome-Wide Scan of C3H/HeJ × APN F2 Mice
      William L. Casley, J. Allan Menzies, Larry W. Whitehouse and Thomas W. Moon
      Drug Metabolism and Disposition December 1999, 27 (12) 1375-1380;

N

  1. Nagai, Yasushi

    1. Absorption, Distribution, Metabolism, and Excretion of Donepezil (Aricept) after a Single Oral Administration to Rat
      Kenji Matsui, Mannen Mishima, Yasushi Nagai, Teruaki Yuzuriha and Tsutomu Yoshimura
      Drug Metabolism and Disposition December 1999, 27 (12) 1406-1414;

  2. Nakajima, Miki

    1. Azelastine N-Demethylation by Cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in Human Liver Microsomes: Evaluation of Approach to Predict the Contribution of Multiple CYPs
      Miki Nakajima, Sumika Nakamura, Shogo Tokudome, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 1999, 27 (12) 1381-1391;
    2. Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
      Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
      Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;
    3. Response to Letter to the Editor
      Kaoru Kobayashi, Miki Nakajima, Kanako Oshima, Noriaki Shimada, Tsuyoshi Yokoi and Kan Chiba
      Drug Metabolism and Disposition December 1999, 27 (12) 1521-1522;

  3. Nakamura, Sumika

    1. Azelastine N-Demethylation by Cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in Human Liver Microsomes: Evaluation of Approach to Predict the Contribution of Multiple CYPs
      Miki Nakajima, Sumika Nakamura, Shogo Tokudome, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 1999, 27 (12) 1381-1391;

O

  1. Oesch, Franz

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

  2. Oshima, Kanako

    1. Response to Letter to the Editor
      Kaoru Kobayashi, Miki Nakajima, Kanako Oshima, Noriaki Shimada, Tsuyoshi Yokoi and Kan Chiba
      Drug Metabolism and Disposition December 1999, 27 (12) 1521-1522;

P

  1. Payan, Jean-Paul

    1. Toxicokinetics of 1,2-Diethylbenzene in Male Sprague-Dawley Rats—Part 1: Excretion and Metabolism of [14C]1,2-Diethylbenzene
      Jean-Paul Payan, Dominique Beydon, Benoît Cossec, André Ensminger, Jean-Paul Fabry and Elisabeth Ferrari
      Drug Metabolism and Disposition December 1999, 27 (12) 1470-1478;

  2. Platt, Karl-Ludwig

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

  3. Poulet, Frederique M.

    1. Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen
      Masahiko Kawai, Stelvio M. Bandiera, Thomas K. H. Chang, Frederique M. Poulet, Paul M. Vancutsem and Gail D. Bellward
      Drug Metabolism and Disposition December 1999, 27 (12) 1392-1398;

R

  1. Ramanathan, Murali

    1. A Method for Estimating Pharmacokinetic Risks of Concentration-Dependent Drug Interactions from Preclinical Data
      Murali Ramanathan
      Drug Metabolism and Disposition December 1999, 27 (12) 1479-1487;

  2. Remmel, Rory P.

    1. Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs
      Vinayak P. Hosagrahara, Linda K. Hansen and Rory P. Remmel
      Drug Metabolism and Disposition December 1999, 27 (12) 1512-1518;

  3. Riska, Paul S.

    1. Biotransformation of Nevirapine, a Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor, in Mice, Rats, Rabbits, Dogs, Monkeys, and Chimpanzees
      Paul S. Riska, David P. Joseph, Roger M. Dinallo, Walter C. Davidson, James J. Keirns and Susan E. Hattox
      Drug Metabolism and Disposition December 1999, 27 (12) 1434-1447;

S

  1. Sauer, John-Michael

    1. Metabolism and Disposition of [14C]1-Nitronaphthalene in Male Sprague-Dawley Rats
      Jason S. Halladay, John-Michael Sauer and I. Glenn Sipes
      Drug Metabolism and Disposition December 1999, 27 (12) 1456-1465;

  2. Shimada, Noriaki

    1. Azelastine N-Demethylation by Cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in Human Liver Microsomes: Evaluation of Approach to Predict the Contribution of Multiple CYPs
      Miki Nakajima, Sumika Nakamura, Shogo Tokudome, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 1999, 27 (12) 1381-1391;
    2. Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
      Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
      Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;
    3. Response to Letter to the Editor
      Kaoru Kobayashi, Miki Nakajima, Kanako Oshima, Noriaki Shimada, Tsuyoshi Yokoi and Kan Chiba
      Drug Metabolism and Disposition December 1999, 27 (12) 1521-1522;

  3. Sipes, I. Glenn

    1. Metabolism and Disposition of [14C]1-Nitronaphthalene in Male Sprague-Dawley Rats
      Jason S. Halladay, John-Michael Sauer and I. Glenn Sipes
      Drug Metabolism and Disposition December 1999, 27 (12) 1456-1465;

  4. Slattery, John T.

    1. Up-Regulation of Glutathione S-Transferase Activity in Enterocytes of Young Children
      John P. Gibbs, Chris A. Liacouras, Robert N. Baldassano and John T. Slattery
      Drug Metabolism and Disposition December 1999, 27 (12) 1466-1469;

  5. Smith, Philip C.

    1. Effect of Selective Phase II Enzyme Inducers on Glucuronidation of Benoxaprofen in Rats
      Jennifer Q. Dong, Amy S. Etheridge and Philip C. Smith
      Drug Metabolism and Disposition December 1999, 27 (12) 1423-1428;

  6. Steinberg, Pablo

    1. Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
      Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
      Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;

T

  1. Tani, Masayoshi

    1. Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
      Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
      Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;

  2. Tokudome, Shogo

    1. Azelastine N-Demethylation by Cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in Human Liver Microsomes: Evaluation of Approach to Predict the Contribution of Multiple CYPs
      Miki Nakajima, Sumika Nakamura, Shogo Tokudome, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 1999, 27 (12) 1381-1391;

  3. Trager, William F.

    1. Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450
      David A. Erickson, Gary Mather, William F. Trager, Rene H. Levy and James J. Keirns
      Drug Metabolism and Disposition December 1999, 27 (12) 1488-1495;

V

  1. Vancutsem, Paul M.

    1. Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen
      Masahiko Kawai, Stelvio M. Bandiera, Thomas K. H. Chang, Frederique M. Poulet, Paul M. Vancutsem and Gail D. Bellward
      Drug Metabolism and Disposition December 1999, 27 (12) 1392-1398;

  2. Venkatakrishnan, Karthik

    1. CYP2C9 Is a Principal Low-Affinity Phenacetin O-Deethylase: Fluvoxamine Is Not a Specific CYP1A2 Inhibitor.
      Karthik Venkatakrishnan, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition December 1999, 27 (12) 1519-1520;

  3. Vincent, Mark D.

    1. Enhancement of Platinum-Drug Cytotoxicity in a Human Head and Neck Squamous Cell Carcinoma Line and its Platinum-Resistant Variant by Liposomal Amphotericin B and Phospholipase A2-II
      Peter J. Ferguson, Catherine Currie and Mark D. Vincent
      Drug Metabolism and Disposition December 1999, 27 (12) 1399-1405;

  4. von Moltke, Lisa L.

    1. CYP2C9 Is a Principal Low-Affinity Phenacetin O-Deethylase: Fluvoxamine Is Not a Specific CYP1A2 Inhibitor.
      Karthik Venkatakrishnan, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition December 1999, 27 (12) 1519-1520;

W

  1. Weimar, William R.

    1. Pharmacokinetics of Orally Administered Desferrithiocin Analogs in Cebus apella Primates
      Raymond J. Bergeron, William R. Weimar and Jan Wiegand
      Drug Metabolism and Disposition December 1999, 27 (12) 1496-1498;

  2. Whitehouse, Larry W.

    1. Detection of Quantitative Trait Loci Affecting Caffeine Metabolism by Interval Mapping in a Genome-Wide Scan of C3H/HeJ × APN F2 Mice
      William L. Casley, J. Allan Menzies, Larry W. Whitehouse and Thomas W. Moon
      Drug Metabolism and Disposition December 1999, 27 (12) 1375-1380;

  3. Wiegand, Jan

    1. Pharmacokinetics of Orally Administered Desferrithiocin Analogs in Cebus apella Primates
      Raymond J. Bergeron, William R. Weimar and Jan Wiegand
      Drug Metabolism and Disposition December 1999, 27 (12) 1496-1498;

X

  1. Xue, Linlong

    1. Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
      Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
      Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;

Y

  1. Yamamoto, Toshinori

    1. Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
      Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
      Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;

  2. Yamazaki, Hiroshi

    1. Azelastine N-Demethylation by Cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in Human Liver Microsomes: Evaluation of Approach to Predict the Contribution of Multiple CYPs
      Miki Nakajima, Sumika Nakamura, Shogo Tokudome, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 1999, 27 (12) 1381-1391;

  3. Yokoi, Tsuyoshi

    1. Azelastine N-Demethylation by Cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in Human Liver Microsomes: Evaluation of Approach to Predict the Contribution of Multiple CYPs
      Miki Nakajima, Sumika Nakamura, Shogo Tokudome, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 1999, 27 (12) 1381-1391;
    2. Response to Letter to the Editor
      Kaoru Kobayashi, Miki Nakajima, Kanako Oshima, Noriaki Shimada, Tsuyoshi Yokoi and Kan Chiba
      Drug Metabolism and Disposition December 1999, 27 (12) 1521-1522;

  4. Yoshimura, Tsutomu

    1. Absorption, Distribution, Metabolism, and Excretion of Donepezil (Aricept) after a Single Oral Administration to Rat
      Kenji Matsui, Mannen Mishima, Yasushi Nagai, Teruaki Yuzuriha and Tsutomu Yoshimura
      Drug Metabolism and Disposition December 1999, 27 (12) 1406-1414;

  5. Yuzuriha, Teruaki

    1. Absorption, Distribution, Metabolism, and Excretion of Donepezil (Aricept) after a Single Oral Administration to Rat
      Kenji Matsui, Mannen Mishima, Yasushi Nagai, Teruaki Yuzuriha and Tsutomu Yoshimura
      Drug Metabolism and Disposition December 1999, 27 (12) 1406-1414;
Back to top

In this issue